Live Breaking News & Updates on Janus Kinase

Stay updated with breaking news from Janus kinase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New Four-Year Sotyktu (deucravacitinib) Data Demonstrate Durable Response Rates and Consistent Safety in Moderate-to-Severe Plaque Psoriasis

Following four years of continuous Sotyktu treatment, clinical response was maintained in more than seven out of 10 patients for Psoriasis Area and Severity Index 75 in the POETYK PSO long-term. ....

United States , Alyssa Johnsen , April Armstrong , Los Angeles , Bristol Myers Squibb , Laboratory Abnormalities , University Of California , Program To , European Academy Of Dermatology , Clinical Trial Program , Exchange Commission , Amgen Inc , Bristol Myers Squibb Company Adverse Event , Psoriasis Area , Severity Index , Global Assessment , European Academy , Spring Symposium , Bristol Myers , Myers Squibb , Pioneering Paths Forward , Transform Patient , Risks Related , Janus Kinase , Bristol Myers Squibb Company , Adverse Event ,

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q1 2024 Earnings Call Transcript

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Latha Vairavan , Serge Belanger , David Topper , Seamus Fernandez , Frank Watanabe , John Smither , Vikram Purohit , Patrick Burnett , Arcutis Biotherapeutic , Emma Guttman , Tyler Van Buren , Patrick Burnet , Todd Edwards , Arcutis Biotherapeutics Inc , Morgan Stanley , Sato Pharmaceutical Company , Exchange Commission , Call Transcript May , Quarter Financial Results Conference , Vice President , Chief Medical Officer , Chief Commercial Officer , Chief Financial , While David ,

AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio

New data for TEZSPIRE and BREZTRI demonstrate AstraZeneca’s innovation and commitment to transform care in COPD

. ....

San Diego , United States , East Sussex , United Kingdom , Sharon Barr , Lymphopoietin Isoforms , American Lung Association , International Conference , Global Initiative On Obstructive Lung Disease , Kyowa Kirin Co Ltd , American Thoracic Society International Conference , Global Asthma Network , Biowa Inc , American Partnership For Eosinophilic Disorders , National Heart , Blood Institute , Centers For Disease , Global Initiative For Chronic Obstructive Lung Disease , American Thoracic Society , Executive Vice President , Biopharmaceuticals Business Unit , Bayesian Dynamic Borrowing Approach , Albuterol Budesonide As Needed , Janus Kinase , British Early , Not Exceed Recommended Dose ,

Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degraders of STAT6

Goal is to develop an oral STAT6 degrader investigational new drug with potential to address the needs of patients with type 2 inflammation Nurix anticipates nominating a clinical candidate within. ....

United States , San Francisco , Arthurt Sands , Elizabeth Wolffe , Jason Kantor , Gwennm Hansen , Aljanae Reynolds , Globenewswire Inc , Nurix Therapeutics Inc , Janus Kinase , Casitasb Lineage , Private Securities Litigation Reform Act , Annual Report ,

Incyte Announces New Data from Phase 2 Study Evaluating Ruxolitinib Cream (Opzelura®) in Patients with Mild-to-Moderate Hidradenitis Suppurativa

Randomized Phase 2 study met the primary endpoint in patents with hidradenitis suppurativa , reinforcing efficacy and safety profile of ruxolitinib cream

Results presented as a late-breaking. ....

United States , San Diego , Hidradenitis Suppurativa , Incyte Corporation , Exchange Commission , Rare Diseases Information Center , National Center , International Hidradenitis Suppurativa Severity Score System , Us Food Drug Administration , European Academy Of Dermatology , American Academy Of Dermatology , Late Breaking Research , American Academy , Annual Meeting , Skin Pain Numeric Rating Scale , Hidradenitis Suppurativa Clinical Response , Drug Administration , Mississippi River , Full Prescribing Information , Boxed Warning , Medication Guide , North America , Advancing Translational Science Genetic , Rare Diseases Information , Accessed February , Janus Kinase ,